Monday, June 1, 2026

Trump was Right? Why Major Markets Are Backtracking on EV Goals in 2025

Global EV policies are shifting, with major nations scaling back targets amid industry pressures and lagging consumer adoption.

APAR Aims for 20-30% Offline Sales Growth in US: What This Means for Beauty Brands

APR plans to boost U.S. offline sales to 20-30% next year, aiming for over 100 billion KRW in revenue through Ulta Beauty and more.

North Korea’s Moranbong Band Deputy Director Hwang Jin Young Passes Away, Honored as National Hero

Hwang Jin Young, deputy director of North Korea's Moranbong Band, passed away, honored for his contributions to Juche music and art.

Tag: PARP inhibitors

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Next-Gen Cancer Drug Nesuparib: How It Outperforms Olaparib in SCLC and Pancreatic Cancer

Onconic Therapeutics will present Nesuparib research at AACR 2026, showcasing its potential for various cancers and overcoming PARP inhibitor limitations.

New Hope for Solid Tumors? Korean Biotech Starts Phase 1 Trial of Targeted Drug

Digmbio secures 12 billion KRW for clinical trials of cancer drug DM5167 and advances treatment for degenerative brain diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.